Galectin Therapeutics Inc SEC filings GALT

Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Galectin Therapeutics Inc SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Oct 13, 2026 —
DEF 14A Proxy statement Oct 13, 2026 Dec 3, 2026
PRE 14A Preliminary proxy statement Oct 2, 2026 Dec 3, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Unregistered share sale
Aug 4, 2026 Jul 31, 2026
8-K Current report
Regulation FD disclosure
Jun 23, 2026 Jun 23, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
EFFECT Filing Apr 10, 2026 —
CORRESP Letter to the SEC Apr 8, 2026 —
UPLOAD Letter from the SEC Apr 6, 2026 —
S-3 Shelf registration Mar 31, 2026 —
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Mar 17, 2026 Mar 12, 2026
8-K Current report
Officer or director change
Jan 21, 2026 Jan 16, 2026
8-K Current report
Officer or director change
Jan 12, 2026 Jan 10, 2026
8-K Current report
Material agreement
Dec 19, 2025 Dec 19, 2025
8-K Current report
Shareholder vote results
Dec 8, 2025 Dec 3, 2025
8-K Current report
Regulation FD disclosure
Dec 3, 2025 Dec 3, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
ARS Annual report to shareholders Oct 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Oct 22, 2025 —
DEF 14A Proxy statement Oct 22, 2025 Dec 3, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, Officer or director change
Jul 9, 2025 Jul 8, 2025
8-K Current report
Regulation FD disclosure
Jun 16, 2025 Jun 16, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure, Other events
May 12, 2025 May 12, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 18, 2025
8-K Current report
Shareholder vote results
Jan 28, 2025 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Jan 23, 2025 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Dec 20, 2024 Dec 20, 2024
ARS Annual report to shareholders Dec 3, 2024 Dec 31, 2023
DEFA14A Additional proxy material Dec 3, 2024 —
DEF 14A Proxy statement Dec 3, 2024 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Aug 1, 2024 Jul 26, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
Mar 29, 2024 Mar 29, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 7, 2023
8-K Current report
Regulation FD disclosure
Dec 7, 2023 Dec 7, 2023
8-K/A Amended current report
Results of operations
Nov 13, 2023 Aug 14, 2023
8-K Current report
Results of operations
Nov 13, 2023 Aug 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
ARS Annual report to shareholders Oct 6, 2023 Dec 31, 2022
DEFA14A Additional proxy material Oct 6, 2023 —
DEF 14A Proxy statement Oct 6, 2023 Dec 7, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
EFFECT Filing Apr 24, 2023 —
CORRESP Letter to the SEC Apr 20, 2023 —
UPLOAD Letter from the SEC Apr 19, 2023 —
S-3 Shelf registration Apr 14, 2023 —
S-8 Employee stock plan registration Mar 30, 2023 —
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Other events
Mar 2, 2023 Mar 2, 2023
8-K Current report
Other events
Jan 5, 2023 Jan 5, 2023
8-K Current report
Shareholder vote results
Dec 6, 2022 Dec 1, 2022
8-K Current report
Regulation FD disclosure
Dec 1, 2022 Dec 1, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
DEFA14A Additional proxy material Oct 17, 2022 —
DEF 14A Proxy statement Oct 17, 2022 Dec 1, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 12, 2022
PRE 14A Preliminary proxy statement Oct 6, 2022 Dec 1, 2022
8-K Current report
Other events
Oct 6, 2022 Oct 6, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
Jul 26, 2022 Jul 25, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Other events
Apr 14, 2022 Apr 14, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Dec 21, 2021 Dec 20, 2021
8-K Current report
Shareholder vote results
Dec 7, 2021 Dec 3, 2021
8-K Current report
Regulation FD disclosure
Dec 3, 2021 Dec 3, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
DEF 14A Proxy statement Oct 12, 2021 Dec 3, 2021
PRE 14A Preliminary proxy statement Sep 22, 2021 Dec 3, 2021
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 21, 2021 Sep 17, 2021
8-K Current report
Regulation FD disclosure
Sep 13, 2021 Sep 13, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure
Jul 26, 2021 Jul 26, 2021
8-K Current report
Other events
Jul 9, 2021 Jul 9, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Apr 19, 2021 Apr 16, 2021
8-K Current report
Results of operations
Mar 31, 2021 Mar 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Mar 9, 2021 Mar 9, 2021
8-K Current report
Shareholder vote results
Dec 7, 2020 Dec 3, 2020
8-K Current report
Regulation FD disclosure
Dec 3, 2020 Dec 3, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
S-8 Employee stock plan registration Nov 9, 2020 —
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
DEF 14A Proxy statement Oct 19, 2020 Dec 3, 2020
8-K Current report
Regulation FD disclosure
Sep 29, 2020 Sep 29, 2020
8-K Current report
Other events
Sep 22, 2020 Sep 22, 2020
8-K Current report
Officer or director change
Sep 2, 2020 Aug 31, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Other events
Jun 30, 2020 Jun 30, 2020
8-K Current report
Material agreement
Jun 26, 2020 Jun 22, 2020
EFFECT Filing May 21, 2020 —
CORRESP Letter to the SEC May 19, 2020 —
UPLOAD Letter from the SEC May 18, 2020 —
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
S-3 Shelf registration May 11, 2020 —
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Other events
Apr 30, 2020 Apr 30, 2020
8-K Current report
Material agreement
Mar 17, 2020 Mar 12, 2020
8-K Current report
Results of operations
Mar 16, 2020 Mar 16, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Feb 20, 2020 Feb 19, 2020
8-K Current report
Shareholder vote results
Dec 6, 2019 Dec 4, 2019
8-K Current report
Regulation FD disclosure
Dec 4, 2019 Dec 4, 2019
8-K Current report
Other events
Nov 26, 2019 Nov 26, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
DEF 14A Proxy statement Oct 17, 2019 Dec 4, 2019
8-K Current report Sep 27, 2019 Sep 25, 2019
8-K Current report
Other events
Sep 17, 2019 Sep 17, 2019
EFFECT Filing Aug 22, 2019 —
UPLOAD Letter from the SEC Aug 22, 2019 —
CORRESP Letter to the SEC Aug 20, 2019 —
S-3 Shelf registration Aug 9, 2019 —
8-K Current report
Results of operations
Aug 9, 2019 Aug 9, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Other events
Aug 5, 2019 Aug 5, 2019
8-K Current report
Other events
May 28, 2019 May 28, 2019
FWP Free writing prospectus May 10, 2019 —
8-K Current report
Other events
May 10, 2019 May 10, 2019
8-K Current report
Acquisition or sale of assets
May 10, 2019 May 10, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
424B1 Form 424(b)(1) Apr 30, 2019 —
8-K Current report
Other events
Apr 15, 2019 Apr 15, 2019
EFFECT Filing Apr 12, 2019 —
CORRESP Letter to the SEC Apr 12, 2019 —
S-3/A Form s-3/a Apr 12, 2019 —
CORRESP Letter to the SEC Apr 10, 2019 —
CORRESP Letter to the SEC Apr 10, 2019 —
S-3/A Form s-3/a Apr 8, 2019 —
8-K Current report
Regulation FD disclosure
Mar 21, 2019 Mar 21, 2019
S-3/A Form s-3/a Mar 20, 2019 —
UPLOAD Letter from the SEC Mar 8, 2019 —
8-K Current report
Other events
Mar 6, 2019 Mar 6, 2019
8-K Current report
Other events
Mar 6, 2019 Mar 6, 2019
8-K Current report
Results of operations
Mar 6, 2019 Mar 6, 2019
S-3 Shelf registration Mar 6, 2019 —
10-K Annual report Mar 6, 2019 Dec 31, 2018
8-K Current report
Officer or director change
Jan 23, 2019 Jan 16, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 15, 2019 Jan 11, 2019
8-K/A Amended current report
Material agreement, New debt, Other events
Jan 3, 2019 Dec 20, 2018
8-K Current report
Other events
Dec 20, 2018 Dec 20, 2018
8-K Current report
Results of operations
Nov 13, 2018 Nov 13, 2018
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q/A Amended quarterly report Sep 28, 2018 Mar 31, 2018
10-K/A Amended annual report Sep 28, 2018 Dec 31, 2017
424B3 Prospectus Sep 25, 2018 —
8-K Current report
Other events
Sep 20, 2018 Sep 20, 2018
EFFECT Filing Sep 10, 2018 —
CORRESP Letter to the SEC Sep 6, 2018 —
S-3/A Form s-3/a Aug 24, 2018 —
8-K Current report
Results of operations
Aug 14, 2018 Aug 14, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
UPLOAD Letter from the SEC Aug 10, 2018 —
S-3 Shelf registration Jul 27, 2018 —
S-8 Employee stock plan registration Jun 26, 2018 —
8-K Current report
Officer or director change
Jun 15, 2018 Jun 14, 2018
8-K Current report
Officer or director change
Jun 12, 2018 Jun 6, 2018
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2018 May 22, 2018
8-K Current report
Other events
May 14, 2018 May 14, 2018
8-K Current report
Results of operations
May 11, 2018 May 11, 2018
10-Q Quarterly report May 11, 2018 Mar 31, 2018
8-K Current report
Regulation FD disclosure, Other events
Apr 16, 2018 Apr 16, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GALT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Norcross, GA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1133416
Former names
PRO PHARMACEUTICALS INC (until May 26, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.